Conference abstract · 18 Jul 2016
Conference abstractPublished 30 Jun 2016
The solubility-permeability interplay and formulation development of low-solubility drugs
Ben-Gurion University of the Negev, Israel
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
While each of the two key parameters of oral drug absorption, the solubility and the permeability, has been comprehensively studied separately, the relationship and interplay between the two has been largely ignored. For instance, when formulating a low-solubility drug using various solubilization techniques, do we know what is the concomitant effect on the apparent permeability? Permeability is equal to the drug's diffusion coefficient through the membrane times the membrane/aqueous partition coefficient divided by the membrane thickness. The direct correlation between the intestinal permeability and the membrane/aqueous partitioning, which in turn is dependent on the drug's apparent solubility in the GI milieu, suggests that the solubility and the permeability are closely associated, exhibiting certain interplay between them, and the current view of treating the one irrespectively of the other may not be sufficient. In this lecture, I will describe the research have been done thus far, and present new data, to shed light on this solubility-permeability interplay. It has been shown that decreased apparent permeability accompanied the solubility increase when using different solubilization methods. On the other hand, we have recently revealed that when increasing the apparent solubility by supersaturation e.g. via amorphous solid dispersions, the solubility-permeability interplay is circumvented, and higher drug flux through the membrane and overall absorption is achieved. Overall, the solubility-permeability interplay cannot be ignored when using solubility-enabling formulations; looking solely at the solubility enhancement that the formulation enables may be misleading with regards to predicting the resulted absorption, and hence, the solubility-permeability interplay must be taken into account to strike the optimal solubility-permeability balance, in order to maximize the overall absorption.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2016
Amorphous solid dispersion (ASD)formulation of the low-solubility drug rifaximine allows overcoming the solubility-permeability tradeoff
Conference abstract
Experimental methods to study interplay of dissolution, solubility and permeability in formulation development
Conference abstract · 26 Jun 2017
Developing better formulations for oral lipophilic drugs by accounting for both the solubility and the intestinal permeability
Commentary · 18 Feb 2022
The Solubility Permeability Interplay and Implications in Manufacture Design and Improvement for Poor Soluble Drugs
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Arik Dahan”
